Abstract
Fungi are often ignored in studies on gut microbes because of their low level of presence (making up only 0.1% of the total microorganisms) in the gastrointestinal tract (GIT) of monogastric animals. Recent studies using novel technologies such as next generation sequencing have expanded our understanding on the importance of intestinal fungi in humans and animals. Here, we provide a comprehensive review on the fungal community, the so-called mycobiome, and their functions from recent studies in humans and mice. In the GIT of humans, fungi belonging to the phyla Ascomycota, Basidiomycota and Chytridiomycota are predominant. The murine intestines harbor a more diverse assemblage of fungi. Diet is one of the major factors influencing colonization of fungi in the GIT. Presence of the genus Candida is positively associated with dietary carbohydrates, but are negatively correlated with dietary amino acids, proteins, and fatty acids. However, the relationship between diet and the fungal community (and functions), as well as the underlying mechanisms remains unclear. Dysbiosis of intestinal fungi can cause invasive infections and inflammatory bowel diseases (IBD). However, it is not clear whether dysbiosis of the mycobiome is a cause, or a result of IBD. Compared to non-inflamed intestinal mucosa, the abundance and diversity of fungi is significantly increased in the inflamed mucosa. The commonly observed commensal fungal species Candida albicans might contribute to occurrence and development of IBD. Limited studies show that Candida albicans might interact with immune cells of the host intestines through the pathways associated with Dectin-1, Toll-like receptor 2 (TLR2), and TLR4. This review is expected to provide new thoughts for future studies on intestinal fungi and for new therapies to fungal infections in the GIT of human and animals.
Similar content being viewed by others
References
Sekirov I, Russell SL, Antunes LC, Finlay BB (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Tremaroli V, Bäckhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249
Cerfbensussan N, Gaboriaurouthiau V (2010) The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 10:735–744
Mao Y (2015) Role of gut microbiota in maternal glucose metabolism. Dissertation, University of Hong Kong
Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65
Arumugam M, Raes J, Pelletier E, Le PD, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM (2011) Enterotypes of the human gut microbiome. Nature 473:174–180
Scupham AJ, Presley LL, Wei B, Bent E, Griffith N, Mcpherson M, Zhu F, Oluwadara O, Rao N, Braun J (2006) Abundant and diverse fungal microbiota in the murine intestine. Appl Environ Microbiol 72:793–801
Hawksworth DL, Rossman AY (1997) Where are all the undescribed fungi? Phytopathology 87:888–891
Soeta N, Terashima M, Gotoh M, Mori S, Nishiyama K, Ishioka K, Kaneko H, Suzutani T (2009) An improved rapid quantitative detection and identification method for a wide range of fungi. J Med Microbiol 58:1037–1044
Valinsky L, Della VG, Jiang T, Borneman J (2002) Oligonucleotide fingerprinting of rRNA genes for analysis of fungal community composition. Appl Environ Microbiol 68:5999–6004
Schoch CL, Consortium FB (2012) Nuclear ribosomal internal transcribed spacer (ITS) region as a universal DNA barcode marker for fungi. Proc Natl Acad Sci U S A 109:6241–6246
Renaud M (2012) Role of gut microbiome-host metabolic interactions in metabolic diseases. Dissertation, Imperial College London
Fukuda S, Ohno H (2013) Gut microbiome and metabolic diseases. Semin Immunopathol 36:103–114
Marteau P, Lepage P, Mangin I, Suau A, Doré J, Pochart P, Seksik P (2015) Gut flora and inflammatory bowel disease. Aliment Pharmacol Ther 20:18–23
Loh G, Blaut M (2012) Role of commensal gut bacteria in inflammatory bowel diseases. Gut Microbes 3:544–555
Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S (2008) Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43:831–841
Iliev ID, Funari VA, Taylor KD, Nguyen Q, Reyes CN, Strom SP, Brown J, Becker CA, Fleshner PR, Dubinsky M (2012) Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314–1317
Ramaswamy K, Correa M, Koshy A (2007) Non-healing gastric ulcer associated with Candida infection. Indian J Med Microbiol 25:57–58
Krause R, Reisinger EC (2005) Candida and antibiotic-associated diarrhoea. Clin Microbiol Infect 11:1–2
Tong Y, Tang J (2017) Candida albicans infection and intestinal immunity. Microbiol Res 198:27–35
Gosiewski T, Salamon D, Szopa M, Sroka A, Malecki MT, Bulanda M (2014) Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes—a pilot study. Gut Pathog 6:43–47
Sonoyama K, Miki A, Sugita R, Goto H, Nakata M, Yamaguchi N (2011) Gut colonization by Candida albicans aggravates inflammation in the gut and extra-gut tissues in mice. Med Mycol 49:237–247
Suhr MJ, Hallenadams HE (2015) The human gut mycobiome: pitfalls and potentials—a mycologist’s perspective. Mycologia 107:1057–1073
Schulze J, Sonnenborn U (2009) Yeasts in the gut: from commensals to infectious agents. Dtsch Arztebl Int 106:837–842
Wheeler ML, Limon JJ, Underhill DM (2016) Immunity to commensal fungi: detente and disease. Annu Rev Pathol 12:359–385
Hamad I, Sokhna C, Raoult D, Bittar F (2012) Molecular detection of eukaryotes in a single human stool sample from Senegal. PLoS One 7:561–567
Scanlan PD, Marchesi JR (2008) Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J 2:1183–1193
Frey-Klett P, Burlinson P, Deveau A, Barret M, Tarkka M, Sarniguet A (2011) Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists. Microbiol Mol Biol Rev 75:583–609
Koh AY (2013) Gastrointestinal colonization of fungi. Curr Fungal Infect Rep 7:144–151
Hoffmann C, Dollive S, Grunberg S, Chen J, Li H, GD W, Lewis JD, Bushman FD (2013) Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS One 8:e66019
Richard ML, Lamas B, Liguori G, Hoffmann TW, Sokol H (2014) Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease. Inflamm Bowel Dis 21:656–665
Mason KL, Downward JRE, Mason KD, Falkowski NR, Eaton KA, Kao JY, Young VB, Huffnagle GB (2012) Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun 80:3371–3380
Angebault C, Djossou F, Abélanet S, Permal E, Ben SM, Diancourt L, Bouchier C, Woerther PL, Catzeflis F, Andremont A (2013) Candida albicans is not always the preferential yeast colonizing humans: a study in Wayampi Amerindians. J Infect Dis 208:1705–1716
Hallen-Adams HE, Kachman SD, Kim J, Legge RM, Martínez I (2015) Fungi inhabiting the healthy human gastrointestinal tract: a diverse and dynamic community. Fungal Ecol 15:9–17
Dollive S, Chen YY, Grunberg S, Bittinger K, Hoffmann C, Vandivier L, Cuff C, Lewis JD, GD W, Bushman FD (2013) Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment. PLoS One 8:e71806
Gouba N, Raoult D, Drancourt M (2014) Eukaryote culturomics of the gut reveals new species. PLoS One 9:e106994
Li Q, Wang C, Tang C, He Q, Li N, Li J (2014) Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease. J Clin Gastroenterol 48:513–523
Pandey PK, Siddharth J, Verma P, Bavdekar A, Patole MS, Shouche YS (2012) Molecular typing of fecal eukaryotic microbiota of human infants and their respective mothers. J Biosci 37:221–226
Ukhanova M, Wang X, Baer DJ, Novotny JA, Fredborg M, Mai V (2014) Effects of almond and pistachio consumption on gut microbiota composition in a randomised cross-over human feeding study. Br J Nutr 111:2146–2152
Li Q, Wang C, Zhang Q, Tang C, Li N, Bing R, Li J (2012) Use of 18S ribosomal DNA polymerase chain reaction–denaturing gradient gel electrophoresis to study composition of fungal community in 2 patients with intestinal transplants. Hum Pathol 43:1273–1281
Sokol H, Leducq V, Aschard H, et al. (2016) Fungal microbiota dysbiosis in IBD. Gut 66:1039–1048
Biasoli MS, Tosello ME, Magaró HM (2002) Adherence of Candida strains isolated from the human gastrointestinal tract. Mycoses 45:465–469
Gouba N, Raoult D, Drancourt M (2014) Gut microeukaryotes during anorexia nervosa: a case report. BMC Res Notes 7:33–36
Suhr MJ, Banjara N, Hallen-Adams HE (2015) Sequence-based methods for detecting and evaluating the human gut mycobiome. Lett Appl Microbiol 62:209–215
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559–563
Gouba N, Raoult D, Drancourt M (2013) Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PLoS One 8:e59474
Penders J (2006) Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:511–521
Kong HH, Morris A (2017) The emerging importance and challenges of the human mycobiome. Virulence 8:310–312
Suhr MJ, Banjara N, Hallen-Adams HE (2016) Sequence-based methods for detecting and evaluating the human gut mycobiome. Lett Appl Microbiol 62:209–215
Rodríguez MM, Pérez D, Chaves FJ, Esteve E, Maringarcia P, Xifra G, Vendrell J, Jové M, Pamplona R, Ricart W (2016) Obesity changes the human gut mycobiome. Sci Rep 6:21679
Zhang L, Mu C, He X, Yong S, Mao S, Jing Z, Smidt H, Zhu W (2016) Effects of dietary fibre source on microbiota composition in the large intestine of suckling piglets. FEMS Microbiol Lett 363:fnw138
Wang ZK, Yang YS, Stefka AT, Sun G, Peng LH (2014) Review article: fungal microbiota and digestive diseases. Aliment Pharmacol Ther 39:751–766
Karkowska-Kuleta J, Kozik A (2015) Cell wall proteome of pathogenic fungi. Acta Biochim Pol 62:339–351
Calich VL, Pina A, Felonato M, Bernardino S, Costa TA, Loures FV (2008) Toll-like receptors and fungal infections: the role of TLR2, TLR4 and MyD88 in paracoccidioidomycosis. FEMS Immunol Med Microbiol 53:1–7
Gross O, Gewies A, Finger K, Schäfer M, Sparwasser T, Peschel C, Förster I, Ruland J (2006) Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651–656
Underhill DM, Iliev ID (2014) The mycobiota: interactions between commensal fungi and the host immune system. Nat Rev Immunol 14:405–416
Taylor PR, Tsoni SV, Willment JA, Dennehy KM, Rosas M, Findon H, Haynes K, Steele C, Botto M, Gordon S (2007) Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 8:31–38
Netea MG, Brown GD, Kullberg BJ, Gow NA (2008) An integrated model of the recognition of Candida albicans by the innate immune system. Nat Rev Microbiol 6:67–78
Dillon S, Agrawal S, Banerjee K, Letterio J, Denning TL, Oswaldrichter K, Kasprowicz DJ, Kellar K, Pare J, Dyke TV (2006) Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest 116:916–928
Romani L (2011) Immunity to fungal infections. Nat Rev Immunol 11:275–288
Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, Elbers CC, Johnson MD, Cambi A, Huysamen C (2009) Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361:1760–1767
Glocker EO, Hennigs A, Nabavi M, Woellner C, Salzer U, Pfeifer D, Veelken H, Warnatz K, Tahami F, Jamal S (2009) A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 361:1727–1735
Mckenzie H, Main J, Pennington CR, Parratt D (1990) Antibody to selected strains of Saccharomyces cerevisiae (baker’s and brewer’s yeast) and Candida albicans in Crohn’s disease. Gut 31:536–538
Colombel JF, Sendid B, Jouault T, Poulain D (2013) Secukinumab failure in Crohn’s disease: the yeast connection? Gut 62:800–801
Qiu X, Zhang F, Yang X, Wu N, Jiang W, Li X, Li X, Liu Y (2015) Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis. Sci Rep 5:10416
Liguori G, Lamas B, Richard ML, Brandi G, Da CG, Hoffmann TW, Di SM, Calabrese C, Poggioli G, Langella P (2015) Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients. J Crohns Colitis 10:296–305
Hoarau G, Mukherjee PK, Gower-Rousseau C, Hager C, Chandra J, Retuerto MA, Neut C, Vermeire S, Clemente J, Colombel JF (2016) Bacteriome and mycobiome interactions underscore microbial dysbiosis in familial Crohn’s disease. MBio 7:e01250–e01216
Nakamura T, Yoshida M, Ishikawa H, Kameyama K, Wakabayashi G, Otani Y, Shimazu M, Tanabe M, Kawachi S, Kumai K (2007) Candida albicans aggravates duodenal ulcer perforation induced by administration of cysteamine in rats. J Gastroenterol Hepatol 22:749–756
Chiaro TR, Soto R, Zac SW, Kubinak JL, Petersen C, Gogokhia L, Bell R, Delgado JC, Cox J, Voth W (2017) A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Sci Transl Med 9:eaaf9044
Vautier S, Drummond RA, Chen K, Murray GI, Kadosh D, Brown AJ, Gow NA, Maccallum DM, Kolls JK, Brown GD (2015) Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cell Microbiol 17:445–450
Naglik JR, Moyes DL, Wächtler B, Hube B (2011) Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect. 13:963–976
Hooper LV, Dan RL, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–1273
Günther Weindl JRN, Kaesler S, Biedermann T, Hube B, Korting HC, Schaller M (2008) Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling. J Clin Invest 117:3664–3672
Weindl G, Wagener J, Schaller M (2010) Epithelial cells and innate antifungal defense. J Dent Res 89:666–675
Urban CF, Ermert D, Schmid M, Abuabed U, Goosmann C, Nacken W, Brinkmann V, Jungblut PR, Zychlinsky A (2009) Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 5:e1000639
Fl VDV, Marijnissen RJ, Kullberg BJ, Koenen HJ, Cheng SC, Joosten I, Wb VDB, Williams DL, Jw VDM, Joosten LA (2009) The macrophage mannose receptor induces IL-17 in response to Candida albicans. Cell Host Microbe 5:329–340
Gringhuis SI, Wevers BA, Kaptein TM, van Capel TM, Theelen B, Boekhout T, de Jong EC, Geijtenbeek TB (2011) Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2. PLoS Pathog. 7:e1001259
Moyes DL, Naglik JR (2011) Mucosal immunity and Candida albicans infection. Clin Dev Immunol 2011:346307
Zelante T, De LA, Bonifazi P, Montagnoli C, Bozza S, Moretti S, Belladonna ML, Vacca C, Conte C, Mosci P (2007) IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 37:2695–2706
Huang W, Na L, Fidel PL, Schwarzenberger P (2004) Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190:624–631
Y Z PAV, DM D YH, SM S QG, AR A ZM, N G FJD, WO (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289
Luca AD, Zelante T, D'Angelo C, Zagarella S, Fallarino F, Spreca A, Iannitti RG, Bonifazi P, Renauld JC, Bistoni F (2010) IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol. 3:361–373
Bai XD, Liu XH, Tong QY (2004) Intestinal colonization with Candida albicans and mucosal immunity. World J Gastroenterology 10:2124–2126
Bujdáková H, Paulovicová E, Borecká-Melkusová S, Gasperík J, Kucharíková S, Kolecka A, Lell C, Jensen DB, Würzner R, Jr CD (2008) Antibody response to the 45 kDa Candida albicans antigen in an animal model and potential role of the antigen in adherence. J Med Microbiol 57:1466–1472
Polonelli L, Ciociola T, Magliani W, Zanello PP, D'Adda T, Galati S, De BF, Arancia S, Gabrielli E, Pericolini E (2012) Peptides of the constant region of antibodies display fungicidal activity. PLoS One 7:e34105
Acknowledgments
The authors thank Prof. André-Denis G. Wright from The University of Arizona and Prof. Weihuan Fang from Zhejiang University for revising the manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (grant number 31301987 and 3167131062).
Author information
Authors and Affiliations
Contributions
Jiayan Li wrote the paper; Daiwen Chen, Bing Yu, and Jun He helped to write the paper; Ping Zheng Xiangbing Mao, Jie Yu, Junqiu Luo, and Gang Tian collected the references; Zhiqing Huang and Yuheng Luo helped to collect the references and revised the paper; Yuheng Luo had primary responsibility for final content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Li, J., Chen, D., Yu, B. et al. Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions. Microb Ecol 75, 821–829 (2018). https://doi.org/10.1007/s00248-017-1105-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00248-017-1105-9